The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
Low-Dose Naltrexone for Treating MS Symptoms
Verywell Health
05 January 2020
https://www.verywellhealth.com/naltrexone-for-ms-2440888
Low-Dose Naltrexone May Be Opioid Replacement for Chronic Pain
Verywell Health
04 March 2021
https://www.verywellhealth.com/low-dose-naltrexone-may-be-opioid-replacement-for-chronic-pain-5115153
NutriChem's LDN Book Event with Dr. Yousuf Siddiqui (Low dose naltrexone) from LDN Research Trust on Vimeo.
Dr. Yousuf Siddiqui, B.Arch.Sci., N.D
Autoimmunity, The Thyroid, Low-dose Naltrexone (LDN) & Beyond
Is fibromyalgia an endocrine/endorphin deficit disorder? Is low dose naltrexone a new treatment option?
Psychosomatics
04 April 2012
https://www.researchgate.net/publication/223962193_Is_Fibromyalgia_An_EndocrineEndorphin_Deficit_Disorder_Is_Low_Dose_Naltrexone_a_New_Treatment_Option
Fibromyalgia, autism, and opioid addiction as natural and induced disorders of the endogenous opioid hormonal system
Discov Med
October 2014
https://www.discoverymedicine.com/Brian-Johnson-2/2014/10/fibromyalgia-autism-and-opioid-addiction-as-natural-and-induced-disorders-of-the-endogenous-opioid-hormonal-system/
The Use of Naltrexone in Low Doses Beyond the Approved Indication [Internet]
Report from Norwegian Knowledge Centre for the Health Services
April 2015
https://pubmed.ncbi.nlm.nih.gov/28510411/
The Safety and Efficacy of Low-Dose Naltrexone in the Management of Chronic Pain and Inflammation in Multiple Sclerosis, Fibromyalgia, Crohn's Disease, and Other Chronic Pain Disorders
Pharmacotherapy
March 2018
https://pubmed.ncbi.nlm.nih.gov/29377216/
The Use and Utility of Low-dose Naltrexone Capsules for Patients with Fibromyalgia
Int J Pharm Compd
June 2018
https://pubmed.ncbi.nlm.nih.gov/29878893/
Efficacy of low dose naltrexone for patients that suffer from comorbid depressive illness
The 15th Pacific Rim College of Psychiatrists Scientific Meeting
October 2012
https://onlinelibrary.wiley.com/doi/pdf/10.1111/appy.12002
Intermittent blockade of OGFr and treatment of autoimmune disorders
Exp Biol Med (Maywood)
December 2018
https://pubmed.ncbi.nlm.nih.gov/30541348/